Client Transactions

The Harvard Drug Group

July 6, 2015 Piper Jaffray co-advises The Harvard Drug Group on $1.1 billion sale to Cardinal Health.

 

Washington

October 15, 2014Piper Jaffray serves as financial advisor for $616.0 million various purpose general obligation refunding bonds.

Recent News

July 23, 2015 Piper Jaffray releases second quarter financial results

July 20, 2015 Piper Jaffray agrees to acquire BMO Capital Markets GKST Inc.